000650.SZ
000650.SZ
CNE000000NF8
RENHE PHARMACY CO LTD
Loading chart...

Company Profile

Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. The company offers Chinese and western medicines; and APIs and health-related products, including oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, external lotions, liniments, suppositories, ointments and other dosage forms of medicines, as well as health-related products. It also provides chemical raw materials and preparations; Chinese medicinal herbs; processed Chinese medicinal herbs; prepared Chinese medicines; antibiotics biological Sexually transmitted drugs; medical devices; sanitary materials; pharmaceutical machinery; and pharmaceutical packaging materials, as well as involved in the pharmaceutical commerce activities. The company was founded in 1996 and is based in Nanchang, China.

Related stocks

300702.SZ
300702.SZ • China
TIANYU PHARMA
22.18 CNY
1.15B USD 1Y -13.6%
301263.SZ
301263.SZ • China
TEK
19.14 CNY
1.22B USD 1Y -31.8%
600195.SS
600195.SS • China
CHINA ANIMAL HUSBANDRY INDUSTRY
6.73 CNY
1.03B USD 1Y -6%
600557.SS
600557.SS • China
JIANGSU KANION PHARMACEUTICAL C
12.4 CNY
1.05B USD 1Y -18.4%
002275.SZ
002275.SZ • China
GLSJ
12.35 CNY
1.09B USD 1Y -16%
002737.SZ
002737.SZ • China
SFPM
11.53 CNY
1.01B USD 1Y -24.8%
600129.SS
600129.SS • China
CHONGQING TAIJI IND
13.97 CNY
1.15B USD 1Y -36.3%
002349.SZ
002349.SZ • China
JINGHUA PHARM
9.24 CNY
1.15B USD 1Y +28.3%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
31.3% p.a.
Max Drawdown (5Y)
-50.5%
Sharpe Ratio (5Y)
-0.39
Beta Factor
0.33
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -60.0% in the extended horizon.
ende